Table 2.
Association between recurrent CNV events and patient’s survival.
| Genome region | Genomic boundary | PFS | OS | ||||
|---|---|---|---|---|---|---|---|
| HR | 95% CI | P-value | HR | 95% CI | P-value | ||
| 17p12 (Amp) | chr17:14248838-15343688 | 0.60 | 0.38-0.95 | 0.02 | 0.82 | 0.40-1.65 | 0.57 |
| 21q22.11 (Amp) | chr21:31066214-31971058 | 0.56 | 0.36-0.87 | 0.01 | 0.75 | 0.39-1.44 | 0.38 |
| 8q24.3 (Del) | chr8:145831032-145998709 | 0.28 | 0.11-0.74 | 0.01 | 0.46 | 0.11-1.92 | 0.27 |
| 20q13.33 (Del) | chr20:59053078-63025520 | 0.43 | 0.19-1.00 | 0.04 | 0.33 | 0.08-1.29 | 0.09 |
| 7p22.3 (Del) | chr7:1-330250 | 0.65 | 0.27-1.53 | 0.32 | 0.27 | 0.01-1.02 | 0.04 |
P-values were calculated by log-rank test.